Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10,536 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predictive Value of the nProfiler 1 Assay for the Efficacy of Adjuvant S-1-Based Doublet Chemotherapy in Stage III Gastric Cancer: A Post-Hoc Analysis of a Randomized Phase III Trial.
Lee DK, Lee CK, Kim HS, Sym SJ, Zang DY, Kim KH, Lim JH, Kim HS, Lee KH, Gee HY, Rha SY, Kim H, Jung M. Lee DK, et al. Among authors: kim h, kim hs, kim kh. Cancer Res Treat. 2024 Nov 12. doi: 10.4143/crt.2024.705. Online ahead of print. Cancer Res Treat. 2024. PMID: 39529388 Free article.
S-1 Based Doublet as an Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer: Results from the Randomized Phase III POST Trial.
Lee CK, Jung M, Kim HS, Jung I, Shin DB, Kang SY, Zang DY, Kim KH, Lee MH, Kim BS, Lee KH, Cheong JH, Hyung WJ, Noh SH, Chung HC, Rha SY. Lee CK, et al. Among authors: kim bs, kim hs, kim kh. Cancer Res Treat. 2019 Jan;51(1):1-11. doi: 10.4143/crt.2018.028. Epub 2018 Feb 5. Cancer Res Treat. 2019. PMID: 29397659 Free PMC article. Clinical Trial.
A Phase 3 Randomized Clinical Trial to Compare Efficacy and Safety between Combination Therapy and Monotherapy in Elderly Patients with Advanced Gastric Cancer (KCSG ST13-10).
Lee KW, Zang DY, Ryu MH, Han HS, Kim KH, Kim MJ, Koh SA, Lee SS, Koo DH, Ko YH, Sohn BS, Kim JW, Park JH, Nam BH, Choi IS. Lee KW, et al. Among authors: kim kh, kim mj, kim jw. Cancer Res Treat. 2023 Oct;55(4):1250-1260. doi: 10.4143/crt.2023.333. Epub 2023 May 25. Cancer Res Treat. 2023. PMID: 37232070 Free PMC article. Clinical Trial.
Prognostic Model to Predict Survival Outcome for Curatively Resected Liposarcoma: A Multi-Institutional Experience.
Oh YJ, Yi SY, Kim KH, Cho YJ, Beum SH, Lee YH, Suh JS, Hur H, Kim KS, Kim SH, Choi YD, Shin KH, Jun HJ, Kim SJ, Lee J, Park SH, Noh SH, Rha SY, Kim HS. Oh YJ, et al. Among authors: kim sh, kim sj, kim ks, kim hs, kim kh. J Cancer. 2016 Jun 7;7(9):1174-80. doi: 10.7150/jca.15243. eCollection 2016. J Cancer. 2016. PMID: 27326262 Free PMC article.
Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG).
Jung M, Ryu MH, Oh DY, Kang M, Zang DY, Hwang IG, Lee KW, Kim KH, Shim BY, Song EK, Sym SJ, Han HS, Park YL, Kim JS, Lee HW, Lee MH, Koo DH, Song HS, Lee N, Yang SH, Choi DR, Hong YS, Lee KE, Maeng CH, Baek JH, Kim S, Kim YH, Rha SY, Cho JY, Kang YK. Jung M, et al. Among authors: kim yh, kim s, kim js, kim kh. Gastric Cancer. 2018 Sep;21(5):819-830. doi: 10.1007/s10120-018-0806-1. Epub 2018 Feb 9. Gastric Cancer. 2018. PMID: 29427038 Clinical Trial.
10,536 results
You have reached the last available page of results. Please see the User Guide for more information.